Immunomodulatory Role of Plants and Their Constituents on the Management of Metabolic Disorders: An Evidence-Based Review
Raden Febriyanti,Jutti Levita,Ajeng Diantini
DOI: https://doi.org/10.2147/dddt.s442566
IF: 4.3188
2024-02-23
Drug Design Development and Therapy
Abstract:Raden Maya Febriyanti, 1, &ast Jutti Levita, 2, &ast Ajeng Diantini 2 1 Department of Biology Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, West Java, 46363, Indonesia; 2 Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, West Java, 46363, Indonesia &astThese authors contributed equally to this work Correspondence: Jutti Levita, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, West Java, 46363, Indonesia, Tel +6222-84288888 Ext 3510, Email The relationship between the immune system and metabolic diseases is complex and increasingly recognized as critical to understanding conditions like obesity, diabetes, and cardiovascular diseases. Modulation of the immune system in patients with metabolic disorders can offer several potential benefits. While the salutary impact of plant-derived bioactive compounds on metabolic and immune functions is acknowledged, there is a paucity of comprehensive reviews on the multifaceted and synergistic mechanisms through which these effects are mediated. This review elucidates the therapeutic potential of phytochemical formulations in ameliorating metabolic disorders and delineates their mechanistic implications on relevant biomarkers and immune modulation. Our analysis reveals a predominance of plant species, including Boswellia serrata, Cinnamomum cassia, Citrus bergamia, Coffea arabica, Ficus racemosa, Momordica charantia, Morus Alba , and Trigonella foenum-graecum , that have undergone clinical evaluation and have been substantiated to confer both metabolic and immunological benefits. The phytoconstituents contained in these plants exert their effects through a range of mechanisms, such as improving glucose regulation, reducing inflammatory responses, and modulating immune system. As such, these findings hold considerable promise for clinical and therapeutic translation and necessitate further empirical validation through randomized controlled trials and mechanistic elucidations to affirm the safety and efficacy of herbal formulations. Keywords: metabolic disease, immune system, phytoconstituents Metabolic disorders encompass a spectrum of conditions that disrupt normal metabolic processes, resulting in various health problems, including type 2 diabetes mellitus (T2DM), obesity, and metabolic syndrome (MetS). 1,2 Furthermore, the pathologies of metabolic diseases are intricate and multifactorial, and elevate the risk for cardiovascular disease (CVD). 3 In their recent article, Saeedi et al reported that 9.3% of the global population (463 million people) was estimated to suffer DM, and this number is expected to increase to 10.2% (578 million) by 2030 and further to 10.9% by 2045. 4 Concurrently, the global prevalence of obesity continues to escalate over the past 50 years, with its consequences encompassing the exacerbation of chronic conditions such as T2DM, coronary heart disease (CHD), hypertension, osteoarthritis, and cancers. 3,5,6 Metabolic diseases and CVD tend to be of long duration and slow progression (chronic) comprising several metabolic disorders due to the involvement of various physiological processes in their development and progression. They are usually the result of genetic, environmental, or lifestyle factors that interfere with the normal functioning of the body's metabolic pathways. Over time, metabolic disorders manifest as a spectrum of intermediate phenotypes, culminating in metabolic syndrome elevating the risk for T2DM and atherosclerotic conditions. 7 People with metabolic disorders can be more susceptible to infectious diseases due to several factors such as a weakened immune system, treatment-related immunosuppression, co-existing health conditions, and overlapping risk factors. Many metabolic conditions, including DM, cancer, and chronic kidney disease (CKD), compromise the immune system, thereby the body is difficult to fight off infections. 8 Concerning the recent pandemic, data indicate a correlation between the severity of COVID-19 and the presence of DM and hyperglycemia. People with DM have been reported to face an augmented risk of SARS-CoV-2 infection, with inadequate glycemic control intensifying treatment and hospitalization necessities and fatality rates. Hyperglycemia, coupled with other risk factors, may tweak immune and inflammatory responses, rendering individuals susceptible to severe COVID-19 manifestations. Complications associated with DM, such as hypertension, obesity, heart failure, and CKDs, further increased COVID-19 mortality risks. 9,10 Notably, the COVID-19 pandemic underscores cardiac patients as particularly vu -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal